Notably, increased Eotaxin (CCL11) levels correlated with a heightened CHD risk, evidenced by an odds ratio (OR) of 1.10 and a 95% confidence interval (CI) of 1.03–1.18 (P = .003). This evidence concerns the gene CCL11 and coronary artery disorder.